Lehi, United States
Xevant, founded in 2017, is at the forefront of the emerging RxTech era. The company specializes in using AI to transform complex pharmacy data into actionable insights that consistently deliver the lowest net pharmacy costs. Operating primarily in the Health Care and Information Technology sectors, Xevant is headquartered in the United States.
With its AI-driven platform, Xevant goes beyond traditional retrospective reporting to offer real-time orchestration of pharmacy benefits. This means continuously identifying opportunities for cost reduction and enhanced outcomes, far beyond mere data analysis. The company's proprietary technology, known as VerX, enables rapid and confident decision-making for plans, employers, and partners, ensuring compounding value over time.
Xevant last received a Venture Round investment on 21 February 2024, with investors such as Tech Council Ventures and HCAP Partners signaling strong market confidence in their innovative approach and leadership in the industry.
